{
    "2018-12-21": [
        [
            {
                "time": "2018-12-21",
                "original_text": "After Hours Most Active for Dec 21, 2018: CSCO, BAC, MSFT, XOM, AAPL, GE, PFE, QQQ, MBI, MU, KGC, FB",
                "features": {
                    "keywords": [
                        "Most Active",
                        "CSCO",
                        "BAC",
                        "MSFT",
                        "XOM",
                        "AAPL",
                        "GE",
                        "PFE"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "energy",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Approval",
                        "RA",
                        "Upadacitinib"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study",
                "features": {
                    "keywords": [
                        "Merck KGaA",
                        "Pfizer",
                        "end",
                        "ovarian cancer",
                        "study"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "Do Analysts See Any Upside for Sarepta Stock?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Upside",
                        "Sarepta",
                        "Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xtandi",
                        "Succeeds",
                        "Prostate Cancer",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "Pfizer and GlaxoSmithKline Form a Joint Venture",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "GlaxoSmithKline",
                        "Joint Venture"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations",
                "features": {
                    "keywords": [
                        "Pharma",
                        "GSK",
                        "PFE",
                        "Consumer Health",
                        "JV",
                        "JNJ",
                        "Talc Allegations"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "Pfizer Discontinues Phase 2b STRIVE Clinical Trial Due To Futility",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Discontinues",
                        "Phase 2b",
                        "STRIVE",
                        "Clinical Trial",
                        "Futility"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}